Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synthetic Vitamin B1 for Post-COVID-19 Fatigue
NCT05642923Phase 4Completed
- Sponsor
- ClinAmygate
- Start
- Jan 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Post COVID-19 Syndrome (PCS) (2 arms), sponsored by ClinAmygate. Primary endpoint: Fatigue scale at 3 months. Started Jan 2023; status: completed.
02
Conditions
Post COVID-19 Syndrome (PCS)
Beyond the preview
Go deeper on NCT05642923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05642923.